Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).
Bourassa MG, Kip KE, Jacobs AK, Jones RH, Sopko G, Rosen AD, Sharaf BL, Schwartz L, Chaitman BR, Alderman EL, Holmes DR, Roubin GS, Detre KM, Frye RL. Bourassa MG, et al. J Am Coll Cardiol. 1999 May;33(6):1627-36. doi: 10.1016/s0735-1097(99)00077-7. J Am Coll Cardiol. 1999. PMID: 10334434 Free article. Clinical Trial.
Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).
Alderman EL, Kip KE, Whitlow PL, Bashore T, Fortin D, Bourassa MG, Lesperance J, Schwartz L, Stadius M; Bypass Angioplasty Revascularization Investigation. Alderman EL, et al. Among authors: bourassa mg. J Am Coll Cardiol. 2004 Aug 18;44(4):766-74. doi: 10.1016/j.jacc.2004.05.041. J Am Coll Cardiol. 2004. PMID: 15312856 Free article. Clinical Trial.
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.
Bourassa MG, Pepine CJ, Forman SA, Rogers WJ, Dyrda I, Stone PH, Chaitman BR, Sharaf B, Mahmarian J, Davies RF, et al. Bourassa MG, et al. J Am Coll Cardiol. 1995 Sep;26(3):606-14. doi: 10.1016/0735-1097(95)00005-o. J Am Coll Cardiol. 1995. PMID: 7642849 Free article. Clinical Trial.
Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the Bypass Angioplasty Revascularization Investigation study (BARI).
Botas J, Stadius ML, Bourassa MG, Rosen AD, Schaff HV, Sopko G, Williams DO, McMilliam A, Alderman EL. Botas J, et al. Among authors: bourassa mg. Am J Cardiol. 1996 Apr 15;77(10):805-14. doi: 10.1016/s0002-9149(97)89173-4. Am J Cardiol. 1996. PMID: 8623731 Free article. Clinical Trial.
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute.
Jacobs AK, Kelsey SF, Yeh W, Holmes DR Jr, Block PC, Cowley MJ, Bourassa MG, Williams DO, King SB 3rd, Faxon DP, Myler R, Detre KM. Jacobs AK, et al. Among authors: bourassa mg. Am J Cardiol. 1997 Oct 15;80(8):979-84. doi: 10.1016/s0002-9149(97)00588-2. Am J Cardiol. 1997. PMID: 9352963 Free article.
386 results